Tekla Cash from 2010 to 2024
| HQL Stock | USD 13.76 0.01 0.07% |
Cash | First Reported 2006-09-30 | Previous Quarter 822 | Current Value 477 | Quarterly Volatility 353 K |
Check Tekla Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 M, Interest Expense of 0.0 or Total Revenue of 28.4 M, as well as many indicators such as Price To Sales Ratio of 15.52, Dividend Yield of 0.0452 or PTB Ratio of 0.71. Tekla financial statements analysis is a perfect complement when working with Tekla Life Valuation or Volatility modules.
Tekla | Cash |
Latest Tekla Life's Cash Growth Pattern
Below is the plot of the Cash of Tekla Life Sciences over the last few years. Cash refers to the most liquid asset of Tekla Life Sciences, which is listed under current asset account on Tekla Life Sciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Tekla Life customers. The amounts must be unrestricted with restricted cash listed in a different Tekla Life account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Tekla Life's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tekla Life's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Tekla Cash Regression Statistics
| Arithmetic Mean | (200,485) | |
| Coefficient Of Variation | (676.31) | |
| Mean Deviation | 635,402 | |
| Median | 990.00 | |
| Standard Deviation | 1,355,897 | |
| Sample Variance | 1.8T | |
| Range | 6.1M | |
| R-Value | (0.13) | |
| Mean Square Error | 1.9T | |
| R-Squared | 0.02 | |
| Significance | 0.65 | |
| Slope | (38,814) | |
| Total Sum of Squares | 25.7T |
Tekla Cash History
Other Fundumenentals of Tekla Life Sciences
Tekla Life Cash component correlations
Click cells to compare fundamentals
About Tekla Life Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Tekla Life income statement, its balance sheet, and the statement of cash flows. Tekla Life investors use historical funamental indicators, such as Tekla Life's Cash, to determine how well the company is positioned to perform in the future. Although Tekla Life investors may use each financial statement separately, they are all related. The changes in Tekla Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tekla Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tekla Life Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tekla Life. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 429.30 | 407.84 | |
| Cash And Short Term Investments | 548.55 | 521.12 | |
| Change In Cash | 36.80 | 38.64 | |
| Free Cash Flow | (0.85) | (0.81) | |
| Begin Period Cash Flow | 400.50 | 380.48 | |
| Other Cashflows From Financing Activities | 76.5 M | 80.3 M | |
| Other Non Cash Items | -20.1 M | -21.1 M | |
| Total Cash From Operating Activities | (0.85) | (0.81) | |
| End Period Cash Flow | 548.55 | 521.12 | |
| Total Cash From Financing Activities | 47.3 M | 49.6 M | |
| Total Cashflows From Investing Activities | -52.4 M | -55 M | |
| Cash Per Share | 0.51 | 0.54 | |
| EV To Operating Cash Flow | -783.1 M | -743.9 M | |
| EV To Free Cash Flow | -783.1 M | -743.9 M | |
| Price To Operating Cash Flows Ratio | -781 M | -742 M | |
| Price To Free Cash Flows Ratio | -781 M | -742 M | |
| Cash Conversion Cycle | 1.3 K | 1.4 K | |
| Price Cash Flow Ratio | -781 M | -742 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Tekla Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Tekla Stock
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:Check out the analysis of Tekla Life Correlation against competitors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Dividend Share 1.3 | Earnings Share 0.79 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.344 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.